• A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia
• A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report
• A Glucagonoma Presenting as Cerebral Vein Thrombosis and Diabetes
• A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas
• A Persistent Migrating Rash
• A Rare Cause of Rash
• A retrospective comparison of robotic versus laparoscopic distal resection and enucleation for potentially benign pancreatic neoplasms
• Advances in basic research on glucagon and alpha cells
• An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
• Analysis of Clinical Characteristics and Survival in Patients With Functional Neuroendocrine Tumors of Gastrointestinal Origin
• Application of Somatostatin, Chemotherapy Combined with TAE in Heterogeneous Glucagonoma Presented with Necrolytic Migratory Erythema
• Benign-Appearing Glucagonoma Undergoing Malignant Transformation after a Prolonged Period
• Bilateral Vestibular Failure May Improve With Treatment of the Underlying Condition: A Report of 2 Cases
• Case of autoimmune progesterone dermatitis presenting as necrotic migratory erythema successfully controlled by danazol
• Case of delayed diagnosis of necrolytic migratory erythema
• Case report of a recurrent resected glucagonoma
• Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network
• Characteristics, therapy, and outcome of rare functioning pancreatic neuroendocrine neoplasms
• Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
• Clinical Characteristics and Management of Functional Pancreatic Neuroendocrine Neoplasms: A Single Institution 20-Year Experience with 286 Patients
• Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study
• Concomitant Insulinoma and Glucagonoma in Solitary Cystic Pancreatic Lesion in a Young Male Patient
• Diabetes Mellitus Secondary to Endocrine Diseases: An Update of Diagnostic and Treatment Particularities
• Diagnosis and comprehensive treatment of a glucagonoma in a patient with residual intrahepatic metastases postoperatively: A case report and literature review
• Diarrhea: a missed D in the 4D glucagonoma syndrome
• Distinctive detection of insulinoma using [¹⁸F]FB(ePEG12)12-exendin-4 PET/CT
• Emerging therapies for advanced insulinomas and glucagonomas
• Erythema as a Visual Surrogate Marker of Glucagonoma
• European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
• Facial edema and erythroderma in a 54 year-old woman
• Genetic disorders and insulinoma/glucagonoma
• Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease
• Glucagonoma - a rare neuroendocrine tumor (NET) that typically originates in the pancreas
• Glucagonoma and Glucagonoma Syndrome: One Center's Experience of Six Cases
• Glucagonoma Syndrome
• Glucagonoma Syndrome
• Glucagonoma syndrome with atypical necrolytic migratory erythema
• Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation
• Glucagonoma syndrome with severe erythematous rash: A rare case report
• Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas
• Glucagonoma with diffuse enlargement of pancreas mimicking autoimmune pancreatitis diagnosed by EUS-guided FNA
• Glucagonoma With Necrolytic Migratory Erythema: Metabolic Profile and Detection of Biallelic Inactivation of DAXX Gene
• Glucagonoma with Paraneoplasic Dermatitis: Diagnosis and Management
• Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy
• Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis
• Glucagonoma-induced Dilated Cardiomyopathy in a Young Woman
• Glucagonoma-related necrolytic migratory erythema
• Glucagonoma: From skin lesions to the neuroendocrine component (Review)
• Hepatic Glucagonoma in a Post-bariatric Female Patient: A Case Report
• How Many Times Can One Go Back to the Drawing Board before the Accurate Diagnosis and Surgical Treatment of Glucagonoma?
• Image Gallery: Necrolytic migratory erythema associated with glucagonoma
• Imaging of Pancreatic-Neuroendocrine Tumours: An Outline of Conventional Radiological Techniques
• Management of functional neuroendocrine tumors of the pancreas
• MANIFESTATIONS OF GLUCAGONOMA SYNDROME
• Metabolic effects of glucagon in humans
• Migratory necrolytic erythema as a manifestation of pancreatic neuroendocrine tumor. Clinical-radiological evaluation
• Molecular imaging of a glucagonoma with (18)F-FDG PET/CT and (68)Ga-DOTATATE PET/CT imaging: A case report and review of the literature
• Molecular imaging of a glucagonoma with ¹⁸F-FDG PET/CT and ⁶⁸Ga-DOTATATE PET/CT imaging: A case report and review of the literature
• Necrolytic Acral Erythema: Current Insights
• Necrolytic migratory erythema
• Necrolytic Migratory Erythema
• Necrolytic Migratory Erythema
• Necrolytic Migratory Erythema Associated with a Glucagonoma
• Necrolytic migratory erythema caused by pancreatic hyperglycemia with emphasis on therapeutic and prognosis: A case report
• Necrolytic migratory erythema in a patient with a glucagonoma
• Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma
• Necrolytic migratory erythema revealing glucagonoma syndrome
• Necrolytic migratory erythema-like eruption and paradoxical psoriasis associated with adalimumab treatment
• Necrolytic migratory erythema: an important sign of glucagonoma
• Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma
• Neuroendorine paraneoplastic syndromes
• Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma
• Occult insulinoma, glucagonoma and pancreatic endocrine pseudotumour in a patient with multiple endocrine neoplasia type 1
• One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones
• Pancreatic Ductal Adenocarcinoma Derived From an Intraductal Papillary Neoplasm With Synchronous Incidental Glucagonoma: A Case Report and Literature Review
• Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging
• Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d'étude des Tumeurs Endocrines) Study
• PARP-14 Promotes Survival of Mammalian α but Not β Pancreatic Cells Following Cytokine Treatment
• Peptidomic analysis of endogenous plasma peptides from patients with pancreatic neuroendocrine tumours
• Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes
• Practical therapeutic approach in the management of diabetes mellitus secondary to Cushing's syndrome, acromegaly and neuroendocrine tumours
• Proof of concept for stereotactic body radiation therapy in the treatment of functional neuroendocrine neoplasms
• Pseudoglucagonoma Syndrome Following Frey's Surgery: A Case Report of a Rare Presentation
• Pseudoglucagonoma syndrome: Description of an 'Idiopatic' case
• Recurrent pruritic polymorphic lesions associated with weight loss
• Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma
• Skin manifestations of neuroendocrine neoplasms: review of the literature
• Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report
• Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important
• Surgical strategies for small sporadic neuroendocrine pancreatic tumors
• Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors
• Synchronous Insulinoma and Glucagonoma: A Review of the Literature
• Systemic and Autoimmune Diseases
• The impact of failure to achieve symptom control after resection of functional neuroendocrine tumors: An 8-institution study from the US Neuroendocrine Tumor Study Group
• The magnesium transporter NIPAL1 is a pancreatic islet-expressed protein that conditionally impacts insulin secretion
• The RNA-binding protein, HuD regulates proglucagon biosynthesis in pancreatic α cells
• Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy
• Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma
• VISUAL VIGNETTE
• Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data